Introducing Radiotherapy in Metastatic Merkel Cell Carcinoma Patients with Limited Progression on Avelumab: An Effective Step against Primary and Secondary Immune Resistance?

Gianluca FeriniValentina ZagardoPaola CritelliAnna SantacaterinaSerena SavaMandara Muralidhar HarikarTejas VenkataramGiuseppe Emmanuele Emmanuele UmanaAnna ViolaVito ValentiStefano Forte

Published in: Journal of personalized medicine (2023)

Adding radiotherapy to mMCC patients with limited progression on avelumab seems to be safe and effective in prolonging the successful use of immunotherapy, regardless of the type of immune refractoriness.

Keyphrases

early stage
locally advanced
radiation therapy
radiation induced
squamous cell carcinoma
small cell lung cancer
rectal cancer